Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2003-10

AUTHORS

T Leong, M Michael, K Foo, A Thompson, D Lim Joon, L Weih, S Ngan, R Thomas, J Zalcberg

ABSTRACT

Chemoradiation is now used more commonly for gastric cancer following publication of the US Intergroup trial results that demonstrate an advantage to adjuvant postoperative chemoradiotherapy. However, there remain concerns regarding the toxicity of this treatment, the optimal chemotherapy regimen and the optimal method of radiotherapy delivery. In this prospective study, we evaluated the toxicity and feasibility of an alternative chemoradiation regimen to that used in the Intergroup trial. A total of 26 patients with adenocarcinoma of the stomach were treated with 3D-conformal radiation therapy to a dose of 45 Gy in 25 fractions with concurrent continuous infusional 5-fluorouracil (5-FU). The majority of patients received epirubicin, cisplatin and 5-FU (ECF) as the systemic component given before and after concurrent chemoradiation. The overall rates of observed grade 3 and 4 toxicities were 38 and 15%, respectively. GIT grade 3 toxicity was observed in 19% of patients, while haematologic grade 3 and 4 toxicities were observed in 23%. Our results suggest that this adjuvant regimen can be delivered safely and with acceptable toxicity. This regimen forms the basis of several new studies being developed for postoperative adjuvant therapy of gastric cancer. More... »

PAGES

1433

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6601311

DOI

http://dx.doi.org/10.1038/sj.bjc.6601311

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017358394

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14562013


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Combined Modality Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epirubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infusions, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoadjuvant Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Conformal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leong", 
        "givenName": "T", 
        "id": "sg:person.0737622114.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737622114.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michael", 
        "givenName": "M", 
        "id": "sg:person.0673420201.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673420201.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Foo", 
        "givenName": "K", 
        "id": "sg:person.01216563465.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216563465.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thompson", 
        "givenName": "A", 
        "id": "sg:person.01215142224.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215142224.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joon", 
        "givenName": "D Lim", 
        "id": "sg:person.010377347207.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010377347207.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weih", 
        "givenName": "L", 
        "id": "sg:person.0734571306.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734571306.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ngan", 
        "givenName": "S", 
        "id": "sg:person.011203322044.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011203322044.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thomas", 
        "givenName": "R", 
        "id": "sg:person.07721206642.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07721206642.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zalcberg", 
        "givenName": "J", 
        "id": "sg:person.01262050434.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262050434.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0277-5379(83)90003-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001674376"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa010187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004811518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199408253310803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011295011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199903253401202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013881402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0958-3947(05)80004-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017609934"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(01)02646-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018814717"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021302636", 
          "https://doi.org/10.1038/bjc.1991.88"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1991.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021302636", 
          "https://doi.org/10.1038/bjc.1991.88"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.1800750206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022309964"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(82)90377-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035073483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(90)90344-j", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035650014"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(80)90164-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037954623"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(94)92464-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038848511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(94)92464-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038848511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039335865", 
          "https://doi.org/10.1038/sj.bjc.6690243"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039335865", 
          "https://doi.org/10.1038/sj.bjc.6690243"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(97)00493-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039512903"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(99)00076-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039795820"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199408000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043280582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00000658-199408000-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043280582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045469768", 
          "https://doi.org/10.1038/sj.bjc.6690350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690350", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045469768", 
          "https://doi.org/10.1038/sj.bjc.6690350"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1023/a:1008377101672", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056303582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/02841860151116385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058315962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1986.4.3.425", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079503460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1986.4.5.685", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079796741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a058932", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082599540"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-10", 
    "datePublishedReg": "2003-10-01", 
    "description": "Chemoradiation is now used more commonly for gastric cancer following publication of the US Intergroup trial results that demonstrate an advantage to adjuvant postoperative chemoradiotherapy. However, there remain concerns regarding the toxicity of this treatment, the optimal chemotherapy regimen and the optimal method of radiotherapy delivery. In this prospective study, we evaluated the toxicity and feasibility of an alternative chemoradiation regimen to that used in the Intergroup trial. A total of 26 patients with adenocarcinoma of the stomach were treated with 3D-conformal radiation therapy to a dose of 45 Gy in 25 fractions with concurrent continuous infusional 5-fluorouracil (5-FU). The majority of patients received epirubicin, cisplatin and 5-FU (ECF) as the systemic component given before and after concurrent chemoradiation. The overall rates of observed grade 3 and 4 toxicities were 38 and 15%, respectively. GIT grade 3 toxicity was observed in 19% of patients, while haematologic grade 3 and 4 toxicities were observed in 23%. Our results suggest that this adjuvant regimen can be delivered safely and with acceptable toxicity. This regimen forms the basis of several new studies being developed for postoperative adjuvant therapy of gastric cancer.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6601311", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "89"
      }
    ], 
    "name": "Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation", 
    "pagination": "1433", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "52b3cd1dd829d92bb3188f855beb73b8f393b26128bb7dbdc7481362475551fa"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14562013"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6601311"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017358394"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6601311", 
      "https://app.dimensions.ai/details/publication/pub.1017358394"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29212_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/6601311"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601311'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601311'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601311'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601311'


 

This table displays all metadata directly associated to this object as RDF triples.

270 TRIPLES      21 PREDICATES      70 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6601311 schema:about N159d09fdd1124c87966d7c1d201439cc
2 N1f21ce2ddf974a4b93df5a31d1205531
3 N25eed8c279de4f9c827946b2f31491dc
4 N343a3ff8038a44ab98edfa8b835119f8
5 N4143aaabe37047d9a2207c08500e9166
6 N42f5bcd0920540ceb0efa65c46618c17
7 N553d0126fd094244b765b62e66f20a99
8 N7c374c8fe0c241b5999c3e44dab3da25
9 N83f5683d58e24c5d9132baca38db3708
10 N9a491bf6fbcc4f7fb056b228b21ba0d5
11 Na149f1e1ad5647aa95072e6272801043
12 Nabea0d65136a4dfb9443884b6d97751d
13 Nb1d2bb01544f42ac9d14f58507c02840
14 Nb795f0e3ab964612be370d33bd6951e5
15 Nb91f890e7a814204a739b975d216a5e5
16 Nb9b8ca42f0d74f5eaf01a4c643a0bd50
17 Nce3dab63ca964ea3998e406062472c56
18 Ne96fe3f1c7c8418091eaddb81d280345
19 Neae98b29c5424788ab6d870a0520ae5d
20 anzsrc-for:11
21 anzsrc-for:1112
22 schema:author Nde61bbcfb59a4550a5e62b6366c5e743
23 schema:citation sg:pub.10.1038/bjc.1991.88
24 sg:pub.10.1038/sj.bjc.6690243
25 sg:pub.10.1038/sj.bjc.6690350
26 https://doi.org/10.1002/bjs.1800750206
27 https://doi.org/10.1016/0277-5379(83)90003-2
28 https://doi.org/10.1016/0360-3016(80)90164-9
29 https://doi.org/10.1016/0360-3016(82)90377-7
30 https://doi.org/10.1016/0360-3016(90)90344-j
31 https://doi.org/10.1016/s0140-6736(94)92464-3
32 https://doi.org/10.1016/s0360-3016(01)02646-3
33 https://doi.org/10.1016/s0360-3016(97)00493-8
34 https://doi.org/10.1016/s0958-3947(05)80004-4
35 https://doi.org/10.1016/s0959-8049(99)00076-3
36 https://doi.org/10.1023/a:1008377101672
37 https://doi.org/10.1056/nejm199408253310803
38 https://doi.org/10.1056/nejm199903253401202
39 https://doi.org/10.1056/nejmoa010187
40 https://doi.org/10.1080/02841860151116385
41 https://doi.org/10.1093/oxfordjournals.annonc.a058932
42 https://doi.org/10.1097/00000658-199408000-00009
43 https://doi.org/10.1200/jco.1986.4.3.425
44 https://doi.org/10.1200/jco.1986.4.5.685
45 schema:datePublished 2003-10
46 schema:datePublishedReg 2003-10-01
47 schema:description Chemoradiation is now used more commonly for gastric cancer following publication of the US Intergroup trial results that demonstrate an advantage to adjuvant postoperative chemoradiotherapy. However, there remain concerns regarding the toxicity of this treatment, the optimal chemotherapy regimen and the optimal method of radiotherapy delivery. In this prospective study, we evaluated the toxicity and feasibility of an alternative chemoradiation regimen to that used in the Intergroup trial. A total of 26 patients with adenocarcinoma of the stomach were treated with 3D-conformal radiation therapy to a dose of 45 Gy in 25 fractions with concurrent continuous infusional 5-fluorouracil (5-FU). The majority of patients received epirubicin, cisplatin and 5-FU (ECF) as the systemic component given before and after concurrent chemoradiation. The overall rates of observed grade 3 and 4 toxicities were 38 and 15%, respectively. GIT grade 3 toxicity was observed in 19% of patients, while haematologic grade 3 and 4 toxicities were observed in 23%. Our results suggest that this adjuvant regimen can be delivered safely and with acceptable toxicity. This regimen forms the basis of several new studies being developed for postoperative adjuvant therapy of gastric cancer.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree true
51 schema:isPartOf Nd5acc2f8653742eba0bb5284f91422fe
52 Ne26ac56cf87b41b79b944ab640e9d916
53 sg:journal.1017082
54 schema:name Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil (ECF) and alternative regimens before and after chemoradiation
55 schema:pagination 1433
56 schema:productId N13f6bb3da33d447ba7500e922ec407f1
57 N726d3c3afa71461cb77607b44e350504
58 N7c3224ec6869418d84c62db1b5e92ae6
59 N9a79181ed15548e0b9bc5cdadea45cfb
60 Nafd2bd9e1cb542d2874bf4cbb4f88db1
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017358394
62 https://doi.org/10.1038/sj.bjc.6601311
63 schema:sdDatePublished 2019-04-11T11:55
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N7b418e198220494d9da359aee1ed6c9c
66 schema:url https://www.nature.com/articles/6601311
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N06ecca51e01c4f5f92fd05d7f81bef0b rdf:first sg:person.01215142224.98
71 rdf:rest N52efe258e47143d38a6be969a24baf9e
72 N13f6bb3da33d447ba7500e922ec407f1 schema:name pubmed_id
73 schema:value 14562013
74 rdf:type schema:PropertyValue
75 N159d09fdd1124c87966d7c1d201439cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Cisplatin
77 rdf:type schema:DefinedTerm
78 N1f21ce2ddf974a4b93df5a31d1205531 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Infusions, Intravenous
80 rdf:type schema:DefinedTerm
81 N1f4cac281b7043d6ba538dea32795871 rdf:first sg:person.01216563465.56
82 rdf:rest N06ecca51e01c4f5f92fd05d7f81bef0b
83 N25eed8c279de4f9c827946b2f31491dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Adenocarcinoma
85 rdf:type schema:DefinedTerm
86 N264ce7e454eb4aa2b91b2e5769073b50 rdf:first sg:person.07721206642.38
87 rdf:rest N972ea49324064250898a95bfc7deb528
88 N343a3ff8038a44ab98edfa8b835119f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Humans
90 rdf:type schema:DefinedTerm
91 N4143aaabe37047d9a2207c08500e9166 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Drug Administration Schedule
93 rdf:type schema:DefinedTerm
94 N42f5bcd0920540ceb0efa65c46618c17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Epirubicin
96 rdf:type schema:DefinedTerm
97 N52efe258e47143d38a6be969a24baf9e rdf:first sg:person.010377347207.91
98 rdf:rest N8fdacd80692c4c9fa259b611af72de38
99 N553d0126fd094244b765b62e66f20a99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Fluorouracil
101 rdf:type schema:DefinedTerm
102 N726d3c3afa71461cb77607b44e350504 schema:name nlm_unique_id
103 schema:value 0370635
104 rdf:type schema:PropertyValue
105 N7b418e198220494d9da359aee1ed6c9c schema:name Springer Nature - SN SciGraph project
106 rdf:type schema:Organization
107 N7c3224ec6869418d84c62db1b5e92ae6 schema:name dimensions_id
108 schema:value pub.1017358394
109 rdf:type schema:PropertyValue
110 N7c374c8fe0c241b5999c3e44dab3da25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Stomach Neoplasms
112 rdf:type schema:DefinedTerm
113 N83f5683d58e24c5d9132baca38db3708 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Combined Modality Therapy
115 rdf:type schema:DefinedTerm
116 N88370a3a651b4c85a611e3e27d7e5308 rdf:first sg:person.011203322044.11
117 rdf:rest N264ce7e454eb4aa2b91b2e5769073b50
118 N8be750e5c9524e4693d819461e5bf166 rdf:first sg:person.0673420201.89
119 rdf:rest N1f4cac281b7043d6ba538dea32795871
120 N8fdacd80692c4c9fa259b611af72de38 rdf:first sg:person.0734571306.25
121 rdf:rest N88370a3a651b4c85a611e3e27d7e5308
122 N972ea49324064250898a95bfc7deb528 rdf:first sg:person.01262050434.01
123 rdf:rest rdf:nil
124 N9a491bf6fbcc4f7fb056b228b21ba0d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N9a79181ed15548e0b9bc5cdadea45cfb schema:name doi
128 schema:value 10.1038/sj.bjc.6601311
129 rdf:type schema:PropertyValue
130 Na149f1e1ad5647aa95072e6272801043 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Aged, 80 and over
132 rdf:type schema:DefinedTerm
133 Nabea0d65136a4dfb9443884b6d97751d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Radiotherapy, Conformal
135 rdf:type schema:DefinedTerm
136 Nafd2bd9e1cb542d2874bf4cbb4f88db1 schema:name readcube_id
137 schema:value 52b3cd1dd829d92bb3188f855beb73b8f393b26128bb7dbdc7481362475551fa
138 rdf:type schema:PropertyValue
139 Nb1d2bb01544f42ac9d14f58507c02840 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 Nb795f0e3ab964612be370d33bd6951e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Antineoplastic Combined Chemotherapy Protocols
144 rdf:type schema:DefinedTerm
145 Nb91f890e7a814204a739b975d216a5e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Adult
147 rdf:type schema:DefinedTerm
148 Nb9b8ca42f0d74f5eaf01a4c643a0bd50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Neoadjuvant Therapy
150 rdf:type schema:DefinedTerm
151 Nce3dab63ca964ea3998e406062472c56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 Nd5acc2f8653742eba0bb5284f91422fe schema:volumeNumber 89
155 rdf:type schema:PublicationVolume
156 Nde61bbcfb59a4550a5e62b6366c5e743 rdf:first sg:person.0737622114.17
157 rdf:rest N8be750e5c9524e4693d819461e5bf166
158 Ne26ac56cf87b41b79b944ab640e9d916 schema:issueNumber 8
159 rdf:type schema:PublicationIssue
160 Ne96fe3f1c7c8418091eaddb81d280345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Chemotherapy, Adjuvant
162 rdf:type schema:DefinedTerm
163 Neae98b29c5424788ab6d870a0520ae5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Aged
165 rdf:type schema:DefinedTerm
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
170 schema:name Oncology and Carcinogenesis
171 rdf:type schema:DefinedTerm
172 sg:journal.1017082 schema:issn 0007-0920
173 1532-1827
174 schema:name British Journal of Cancer
175 rdf:type schema:Periodical
176 sg:person.010377347207.91 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
177 schema:familyName Joon
178 schema:givenName D Lim
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010377347207.91
180 rdf:type schema:Person
181 sg:person.011203322044.11 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
182 schema:familyName Ngan
183 schema:givenName S
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011203322044.11
185 rdf:type schema:Person
186 sg:person.01215142224.98 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
187 schema:familyName Thompson
188 schema:givenName A
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215142224.98
190 rdf:type schema:Person
191 sg:person.01216563465.56 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
192 schema:familyName Foo
193 schema:givenName K
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216563465.56
195 rdf:type schema:Person
196 sg:person.01262050434.01 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
197 schema:familyName Zalcberg
198 schema:givenName J
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262050434.01
200 rdf:type schema:Person
201 sg:person.0673420201.89 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
202 schema:familyName Michael
203 schema:givenName M
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673420201.89
205 rdf:type schema:Person
206 sg:person.0734571306.25 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
207 schema:familyName Weih
208 schema:givenName L
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0734571306.25
210 rdf:type schema:Person
211 sg:person.0737622114.17 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
212 schema:familyName Leong
213 schema:givenName T
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0737622114.17
215 rdf:type schema:Person
216 sg:person.07721206642.38 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
217 schema:familyName Thomas
218 schema:givenName R
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07721206642.38
220 rdf:type schema:Person
221 sg:pub.10.1038/bjc.1991.88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021302636
222 https://doi.org/10.1038/bjc.1991.88
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/sj.bjc.6690243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039335865
225 https://doi.org/10.1038/sj.bjc.6690243
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/sj.bjc.6690350 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045469768
228 https://doi.org/10.1038/sj.bjc.6690350
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1002/bjs.1800750206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022309964
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1016/0277-5379(83)90003-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001674376
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/0360-3016(80)90164-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037954623
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/0360-3016(82)90377-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035073483
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1016/0360-3016(90)90344-j schema:sameAs https://app.dimensions.ai/details/publication/pub.1035650014
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/s0140-6736(94)92464-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038848511
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/s0360-3016(01)02646-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018814717
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/s0360-3016(97)00493-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039512903
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s0958-3947(05)80004-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017609934
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1016/s0959-8049(99)00076-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039795820
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1023/a:1008377101672 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056303582
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1056/nejm199408253310803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011295011
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1056/nejm199903253401202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013881402
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1056/nejmoa010187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004811518
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1080/02841860151116385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058315962
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1093/oxfordjournals.annonc.a058932 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082599540
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1097/00000658-199408000-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043280582
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1200/jco.1986.4.3.425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079503460
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1200/jco.1986.4.5.685 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079796741
267 rdf:type schema:CreativeWork
268 https://www.grid.ac/institutes/grid.1055.1 schema:alternateName Peter MacCallum Cancer Centre
269 schema:name Peter MacCallum Cancer Centre, St Andrews Place, Melbourne, Victoria 3002, Australia
270 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...